This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cerávolo, I. P.
Right arrow Articles by Gazzinelli, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cerávolo, I. P.
Right arrow Articles by Gazzinelli, R. T.

 Previous Article  |  Next Article 

Infection and Immunity, May 1999, p. 2233-2240, Vol. 67, No. 5
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Replication of Toxoplasma gondii, but Not Trypanosoma cruzi, Is Regulated in Human Fibroblasts Activated with Gamma Interferon: Requirement of a Functional JAK/STAT Pathway

Isabela Penna Cerávolo,1 Andréa C. L. Chaves,1 Cláudio A. Bonjardim,2 David Sibley,3 Alvaro J. Romanha,1 and Ricardo T. Gazzinelli4,5,*

Cellular and Molecular Parasitology Laboratory1 and Chagas' Disease Laboratory,5 Centro de Pesquisas René Rachou, FIOCRUZ, and Viruses Laboratory, Microbiology Department,2 and Biochemistry and Immunology Department,4 ICB, UFMG, Belo Horizonte, Brazil, and Molecular Microbiology Department, Washington University, St. Louis, Missouri3

Received 28 September 1998/Returned for modification 18 November 1998/Accepted 12 February 1999

To study the role of tryptophan degradation by indoleamine 2,3-dioxygenase (INDO) in the control of Trypanosoma cruzi or Toxoplasma gondii replication, we used human fibroblasts and a fibrosarcoma cell line (2C4). The cells were cultured in the presence or absence of recombinant gamma interferon (rIFN-gamma ) and/or recombinant tumor necrosis factor alpha (rTNF-alpha ) for 24 h and were then infected with either T. cruzi or T. gondii. Intracellular parasite replication was evaluated 24 or 48 h after infection. Treatment with rIFN-gamma and/or rTNF-alpha had no inhibitory effect on T. cruzi replication. In contrast, 54, 73, or 30% inhibition of T. gondii replication was observed in the cells treated with rIFN-gamma alone, rIFN-gamma plus rTNF-alpha , or TNF-alpha alone, respectively. The replication of T. gondii tachyzoites in cytokine-activated cells was restored by the addition of extra tryptophan to the culture medium. Similarly, T. gondii tachyzoites transfected with bacterial tryptophan synthase were not sensitive to the microbiostatic effect of rIFN-gamma . We also investigated the basis of the cytokine effect on parasite replication by using the three mutant cell lines B3, B9, and B10 derived from 2C4 and expressing defective STAT1alpha (signal transducer and activator of transcription), JAK2 (Janus family of cytoplasmic tyrosine kinases), or JAK1, respectively, three important elements of a signaling pathway triggered by rIFN-gamma . We found that rTNF-alpha was able to induce low levels expression of INDO mRNA in the parental cell line, as well as the cell line lacking functional JAK2. In contrast to the parental cell line (2C4), rIFN-gamma was not able to induce the expression of INDO mRNA or microbiostatic activity in any of the mutant cell lines. These findings indicate the essential requirement of the JAK/STAT pathway for the induction of high levels of INDO mRNA, tryptophan degradation, and the anti-Toxoplasma activity inside human nonprofessional phagocytic cells.


* Corresponding author. Mailing address: Laboratory of Chagas' Disease, CPqRR-FIOCRUZ, CEP 30190-002, Cx. Postal 1743, Av. Augusto de Lima 1715, Belo Horizonte, MG 30190-002, Brazil. Phone: 031-295-3566. Fax: 031-295-3115. E-mail: ritoga{at}mono.icb.ufmg.br.


Infection and Immunity, May 1999, p. 2233-2240, Vol. 67, No. 5
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Kim, S.-K., Fouts, A. E., Boothroyd, J. C. (2007). Toxoplasma gondii Dysregulates IFN-{gamma}-Inducible Gene Expression in Human Fibroblasts: Insights from a Genome-Wide Transcriptional Profiling. J. Immunol. 178: 5154-5165 [Abstract] [Full Text]  
  • Souza, P. E. A., Rocha, M. O. C., Rocha-Vieira, E., Menezes, C. A. S., Chaves, A. C. L., Gollob, K. J., Dutra, W. O. (2004). Monocytes from Patients with Indeterminate and Cardiac Forms of Chagas' Disease Display Distinct Phenotypic and Functional Characteristics Associated with Morbidity. Infect. Immun. 72: 5283-5291 [Abstract] [Full Text]  
  • Collazo, C. M., Yap, G. S., Hieny, S., Caspar, P., Feng, C. G., Taylor, G. A., Sher, A. (2002). The Function of Gamma Interferon-Inducible GTP-Binding Protein IGTP in Host Resistance to Toxoplasma gondii Is Stat1 Dependent and Requires Expression in Both Hematopoietic and Nonhematopoietic Cellular Compartments. Infect. Immun. 70: 6933-6939 [Abstract] [Full Text]  
  • Silva, N. M., Rodrigues, C. V., Santoro, M. M., Reis, L. F. L., Alvarez-Leite, J. I., Gazzinelli, R. T. (2002). Expression of Indoleamine 2,3-Dioxygenase, Tryptophan Degradation, and Kynurenine Formation during In Vivo Infection with Toxoplasma gondii: Induction by Endogenous Gamma Interferon and Requirement of Interferon Regulatory Factor 1. Infect. Immun. 70: 859-868 [Abstract] [Full Text]